Clinical, Genetic, and Immunological Spectrum of CHAI and LATAIE Patients from a Tertiary Referral Centre in India

印度一家三级转诊中心的CHAI和LATAIE患者的临床、遗传和免疫学谱

阅读:2
作者:Priyanka Setia,Umair Ahmed Bargir,Mukesh Desai,Aparna Dalvi,Shweta Shinde,Neha Jodhawat,Pallavi Gaikwad,Sagar Bhattad,Chandrakala Shainmukhaih,Maya Gupta,Amruta Dhawale,Priyanka Kambli,Reetika Malik Yadav,Manas Kalra,Harikrishnan Gangadharan,Meena Sivasankaran,Vibha Bafna,Prawin Kumar,Priya Sarvanan,Mamta Manglani,Ratna Sharma,Parag Tamhankar,Manisha Madkaikar

Abstract

Primary immune regulatory disorders (PIRDs) are a group of conditions characterised by a loss of immune tolerance. Two such disorders, CHAI and LATAIE, share common molecular mechanisms, leading to significant clinical overlap. Here, we report demographic, clinical, immunological, and molecular findings in 29 patients referred from different parts of India with a diagnosis of CHAI or LATAIE. LATAIE patients demonstrated a higher prevalence of consanguinity, while CHAI patients more often had a positive family history. Both disorders presented with overlapping clinical features, predominately autoimmune cytopenias, benign lymphoproliferation, and inflammatory bowel disease (IBD). However, the incidence of recurrent infections, otitis media, bronchiectasis, and hypogammaglobulinemia was higher among LATAIE patients as compared to CHAI. Flow cytometry analysis revealed significant differences in T cell subsets, particularly in percentages of CD4+ naïve cells and T regulatory cells (Treg), between the two disorders. B cell abnormalities were also observed. Molecular diagnosis was achieved using targeted or clinical exome sequencing, and specific protein expression was employed to validate the novel variants.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。